Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Grove

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The International Journal of Biostatistics|August 1, 2012
Regression calibration with heteroscedastic error varianceDonna Spiegelman, Roger Logan, Douglas Grove
JMIR Research Protocols|October 5, 2018
Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled TrialKathryn Therese Mngadi, Bhavna Maharaj, Yajna Duki, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 6, 2004
Treatment of oralfacial clefts by state-affiliated craniofacial centers and cleft palate clinicsCharles A Williams, Russell E Mardon, Douglas Grove, et al.
Biostatistics (Oxford, England)|March 18, 2005
Denoising array-based comparative genomic hybridization data using waveletsLi Hsu, Steven G Self, Douglas Grove, et al.
Statistical Communications in Infectious Diseases|November 28, 2012
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensPeter B Gilbert, Douglas Grove, Erin Gabriel, et al.
Journal of Virology|January 30, 2009
Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infectionsAndrea R Stacey, Philip J Norris, Li Qin, et al.
The Journal of Infectious Diseases|February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy TrialHolly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The International Journal of Biostatistics|August 1, 2012
Regression calibration with heteroscedastic error varianceDonna Spiegelman, Roger Logan, Douglas Grove
JMIR Research Protocols|October 5, 2018
Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled TrialKathryn Therese Mngadi, Bhavna Maharaj, Yajna Duki, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 6, 2004
Treatment of oralfacial clefts by state-affiliated craniofacial centers and cleft palate clinicsCharles A Williams, Russell E Mardon, Douglas Grove, et al.
Biostatistics (Oxford, England)|March 18, 2005
Denoising array-based comparative genomic hybridization data using waveletsLi Hsu, Steven G Self, Douglas Grove, et al.
Statistical Communications in Infectious Diseases|November 28, 2012
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensPeter B Gilbert, Douglas Grove, Erin Gabriel, et al.
Journal of Virology|January 30, 2009
Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infectionsAndrea R Stacey, Philip J Norris, Li Qin, et al.
The Journal of Infectious Diseases|February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy TrialHolly E Janes, Kristen W Cohen, Nicole Frahm, et al.
Pageof 1